Concert Pharma (CNCE) Announces $65M Institutional Financing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Concert Pharma (CNCE) Announces $65M Institutional Financing

Concert Pharmaceuticals Announces $65 Million Financing

November 4, 2021 7:00 AM EDT

Financing Provided by Leading Healthcare Funds BVF Partners L.P. and RA Capital Management

LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has entered into an agreement with BVF Partners L.P. (BVF) and RA Capital Management (RA) to raise gross proceeds of $65 million. In addition, Concert will have the potential to receive an additional $103 million upon the full exercise of warrants being issued in connection with the agreement. Closing of the financing is expected on or about November 5, 2021.... More